Leadership & Pay ·
Appoints Stephanie Horn-Warnock as CFO after Constance Ames resigns
TPSTTempest Therapeutics, Inc.
Tempest Therapeutics announced that Constance Ames resigned immediately as Chief Financial Officer for personal reasons. The Board appointed Stephanie Horn-Warnock as the new CFO, Principal Financial and Accounting Officer, Treasurer, and Corporate Secretary. Ms. Horn-Warnock will serve as a consultant at $450 per hour plus expenses under an engagement letter dated October 28, 2026. She brings over 14 years of experience in accounting and financial management across healthcare and pharmaceutical sectors. Tempest Therapeutics operates in the biotechnology industry.